Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5002 Cowhorn Creek Rd
Texarkana, TX 75503Phone+1 903-614-3000Fax+1 903-614-3525
Summary
- Dr. Malcolm Smith is a pulmonologist in Texarkana, TX and is affiliated with multiple hospitals in the area, including Wadley Regional Medical Center and CHRISTUS St. Michael Health System. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine and has been in practice 27 years. He specializes in critical care medicine, interventional pulmonology, and sleep medicine and is experienced in critical care medicine.
Education & Training
- Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
- Emory University School of MedicineResidency, Internal Medicine, 1990 - 1993
- University of Arkansas For Medical Sciences College of MedicineClass of 1990
Certifications & Licensure
- TX State Medical License 1996 - 2024
- OK State Medical License 2020 - 2020
- GA State Medical License 1993 - 1997
- AR State Medical License 1990 - 1991
- National Board of Physicians and Surgeons Critical Care Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
- National Board of Physicians and Surgeons Sleep Medicine
Publications & Presentations
PubMed
- 190 citationsRecurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms TumorsAmy L. Walz, Ariadne H. A. G. Ooms, Samantha Gadd, Daniela S. Gerhard, Malcolm A. Smith
Cancer Cell. 2015-02-09 - 44 citationsEvaluation of alternative in vivo drug screening methodology: A single mouse analysisBrendan Murphy, Han Yin, John M. Maris, E. Anders Kolb, Richard Gorlick
Cancer Research. 2016-10-01 - 30 citationsInitial testing of the CENP‐E inhibitor GSK923295A by the pediatric preclinical testing programRichard B. Lock, Hernan Carol, Christopher L. Morton, Stephen T. Keir, C. Patrick Reynolds
Pediatric Blood & Cancer. 2012-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: